Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 9,354 CGON shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | CG Oncology, Inc. (CGON) | Grant/Award | 9,354 | n/a |
| Nov 26, 2025 | CG Oncology, Inc. (CGON) | Grant/Award | 20,889 | n/a |
| Jun 12, 2025 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 31,000 | n/a |
| Jul 8, 2024 | Blueprint Medicines Corp (BPMC) | Grant/Award | 9,625 | n/a |
| Jun 17, 2024 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 25,000 | n/a |
| Mar 11, 2024 | Blueprint Medicines Corp (BPMC) | Sale | 6,070 | $550.5K |
| Mar 6, 2024 | Blueprint Medicines Corp (BPMC) | Grant/Award | 15,000 | n/a |
| Jun 13, 2023 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 13,200 | n/a |
| Jun 17, 2022 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 13,200 | n/a |